Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Healthcare Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:RVX)

Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024

Newsfile September 3, 2024

Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension

Newsfile July 31, 2024

Resverlogix Provides Update Regarding Two-Year Extension of Debenture and Elimination of Conversion Privileges

Newsfile July 16, 2024

Resverlogix Announces Updated Annual and Special Meeting of Shareholders

Newsfile May 28, 2024

Resverlogix Announces Two-Year Extension of Debenture and Elimination of Conversion Privileges

Newsfile May 13, 2024

Resverlogix Announces Change to Its Board of Directors

Newsfile February 21, 2024

Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits

Newsfile January 11, 2024

Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

Newsfile October 4, 2023

Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes

Newsfile August 29, 2023
View More News ››

Opinion & Analysis (TSX:RVX)

Buzz on the Bullboards: Will Cooler Heads Prevail?

Omri Wallach October 3, 2019

'Pivotal Topline Up Next' for Biotech's Phase 3 Cardiac Clinical Trial

Streetwise Reports May 2, 2019

Biotech’s Lead Drug Candidate Targets 'Market with Huge Potential'

Streetwise Reports November 2, 2018

Biotech's shares 'undervalued' and positioned for 'long-term upside potential'

Streetwise Reports December 28, 2017

Biotech receives 'major endorsement from world-leading pharma company'

Streetwise Reports December 21, 2017

Coverage initiated on 'one of the most undervalued biotech companies in Canada'

Streetwise Reports December 8, 2017
View More Opinion ››

Bullboard Posts (TSX:RVX)

long covid trial finaly recruiting?

pretty much given up on this and waiting to be delisted... looks like we might be recruiting - 1 of 3 sites?  Dubai UAE...
general360 - April 29, 2025

AGM

Not expecting in person meeting,webcast about nothing.No accountability on lying dons part.To bad he can't share a cell with bernie m...
Storm23 - April 22, 2025

Promissory Notes

With all the money that's been lent to Zen,you would think they have a greater grasp of what's going on with a potential deal...
Storm23 - November 24, 2024

RE:Promissory Notes

the people giving the loans have about as much chance of getting their money back as I do. never mind the interest.  12% of NOTHING...
general360 - November 13, 2024

Promissory Notes

Are they just about making 12% on their money for a year or do these people believe there's more money to be made,that is my question...
Storm23 - November 6, 2024

RE:Progress

Hi Toninv; yeah, i heard that too in the last prezzy... i wondered if i heard it correctly cause when it was said it was said w...
general360 - November 6, 2024
View more Bullboard ››

G Mining Ventures Corp.

G Mining Ventures Corp.

G Mining Ventures Corp. is a Canada-based mining company. The Company is engaged in the acquisition, exploration and ...
View More »